Table 3.
Characteristics of HIV-infected infants traced to the Baylor COE stratified by point of entry.
| All Infants (%) | Outpatients (%) | Inpatients (%) | P-Value | |
|---|---|---|---|---|
| Total clients traced,1 n/N (%) | 202 (100.0) | 145/202 (71.8) | 57/202 (28.2) | NS |
| Females, n/N (%) | 108/202 (53.0) | 80/145 (55.2) | 28/57 (49.1) | NS |
| WHO stage at clinic enrollment, n/N (%) | ||||
| 1 | 107/202 (53.0) | 90/145 (62.1) | 17/57 (29.8) | NS |
| 2 | 19/202 (9.4) | 11/145 (7.6) | 8/57 (14.0) | NS |
| 3 | 48/202 (23.8) | 29/145 (20.0) | 19/57 (33.3) | NS |
| 4 | 13/202 (6.4) | 7/145 (4.8) | 6/57 (10.5) | NS |
| Not available | 15/202 (7.4) | 8/145 (5.5) | 7/57 (12.3) | NS |
| ART initiation, n/N (%) | 110/202 (54.5) | 83/145 (57.2) | 27/57 (47.4) | NS |
| Age < 12 months at ART initiation, n/N (%) | 77/110 (70.0) | 65/83 (78.3) | 12/27 (44.4) | NS |
| Outcome, n/N (%) | ||||
| Alive | 120/202 (59.4) | 88/145 (60.7) | 32/57 (56.1) | NS |
| Death | 43/202 (21.3) | 27/145 (18.6) | 16/57 (38.6) | NS |
| Loss to follow-up | 26/202 (12.9) | 20/145 (13.8) | 6/57 (10.5) | |
| Transferred out | 13/202 (6.4) | 10/145 (6.9) | 3/57 (5.3) | NS |
| Age at diagnosis (mos, median (IQR)) | 3.0 (0.5-8.6) | 2.0 (0.2-3.9) | 10.2 (6.5-15.7) | <0.001 |
| Age at enrollment (mos, median (IQR)) | 5.5 (2.7 – 10.0) | 4.2 (2.3-7.7) | 10.0 (6.5-15.7) | <0.001 |
| ART initiators | All (N=110) | Outpatient (N=83) | Inpatient (N=27) | P-Value |
|---|---|---|---|---|
| Age at ART initiation (mos, median (IQR)) | 9.1 (5.4-13.8) | 8.3 (5.0-11.5) | 12.7 (9.8-16.6) | 0.009 |
| Time from enrollment to ART initiation (mos, median (IQR)) | 2.5 (1.4 – 5.2) | 2.5 (1.2 – 5.6) | 2.5 (1.5 – 5.2) | NS |
| Time on ART (mos, median (IQR)) | 7.4 (3.8 – 13.1) | 7.8 (4.5 – 15.2) | 5.4 (3.1 – 9.6) | 0.0204 |
ART, antiretroviral therapy; mos, months; IQR, interquartile range; SD, standard deviation; NS, not significant, COE, Center of Excellence
1
Nineteen traced infants were excluded from outcomes analysis due to incomplete documentation.